Trump’s Diabetes Funding Yo-Yo: Columbia’s Science Soap Opera
The Trump administration rolled the federal funding dice on Columbia University's landmark diabetes study, cutting it initially but later restoring it—kind of like a bad sequel nobody asked for. This study, a diabetes heavyweight champion, faced a rollercoaster of budget snips that didn’t just leave scientists grumbling but left the science itself limping. The cuts hit like a reality TV breakup: messy, dramatic, and leaving long-lasting scars. Imagine curing or managing diabetes depending on which administration’s funding mood swings landed on your researchers. Columbia’s study is now the scientific equivalent of that friend who binges and then swears off Netflix... temporarily.
Share the Story
Cut federal funding, then restore it like a bad Wi-Fi signal, and Columbia's diabetes study just can’t catch a break—it’s science on life support with a side of political drama.
Turning scientific research funding into a yo-yo trick: shoot it down, pick it back up, and repeat until everyone’s dizzy or diabetes is cured—whichever comes first.
Columbia’s diabetes study got more mood swings than your group chat during a family argument—funding cut, funding back, and still nobody’s diabetes-free.
Source: Statnews | Published: 8/30/2025 | Author: Jonathan Saltzman — Boston Globe
More Articles in Health
Sam Altman’s Hospital Stay: AI Genius Vs. Semaglutide Junk Food
TrumpRX: Medicare’s New Weight Loss Coke—Now in Pill Form!
90-Year-Old Powerlifters Crush Age, Bones, and Expectations
Forty-Something Brits Take on Identical Triplets: Sleep, Who Needs It?
Pickleball Achilles: From Court Pop to Star-Powered Sobfest
